Liu S; Fan M; Xu J X, et al., Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology. J Neuroinflammation 2022, 19 (1), 35.
Liu W; Liu X; Gao Y, et al., Discovery of novel beta-carboline derivatives as selective AChE inhibitors with GSK-3beta inhibitory property for the treatment of Alzheimer's disease. Eur J Med Chem 2022, 229, 114095.
Jiang S; Borjigin G; Sun J, et al., Identification of Uncaria rhynchophylla in the Potential Treatment of Alzheimer's Disease by Integrating Virtual Screening and In Vitro Validation. Int J Mol Sci 2023, 24 (20).
Liu W; Liu X; Tian L, et al., Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3beta/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. Eur J Med Chem 2021, 222, 113554.
Luo Z; Wan Q; Han Y, et al., CAPE-pNO2 ameliorates diabetic brain injury through modulating Alzheimer's disease key proteins, oxidation, inflammation and autophagy via a Nrf2-dependent pathway. Life Sci 2021, 287, 119929.
Chen H; Yu C; Liu W, et al., Discovery of novel alpha-carboline derivatives as glycogen synthase kinase-3beta inhibitors for the treatment of Alzheimer's disease. Arch Pharm (Weinheim) 2022, e2200156.
Wei Y D; Chen X X; Yang L J, et al., Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice. Neurochem Int 2022, 159, 105385.
